In mammary tumors, pSTAT3 has also been shown to control ER Ca2+ flux via interacting inositol 1,4,5-triphosphate receptor (IP3R3) results proteasomal degradation of IP3R3 and inhibits oxidative/ER stress and apoptosis [133]. Here, ITPR3 is linked to breast cancer.